Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Lake Street analyst Brooks O’Neil maintained a Buy rating on LifeVantage (LFVN – Research Report) today and set a price target of $26.00. The ...

LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...

As the U.S. stock market navigates a mixed landscape with the S&P 500 inching higher and tech stocks experiencing volatility, investors are keenly observing growth companies with substantial insider ...

LifeVantage's (NASDAQ:LFVN) stock is up by a considerable 55% over the past three months. Given that stock prices ...

InvestingPro subscribers can access 14+ additional investment tips and comprehensive analysis through the Pro Research Report, offering deeper insights into LifeVantage's growth trajectory and ...

LifeVantage was founded in 2003 and is headquartered ... unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may ...

InvestingPro subscribers can access 14+ additional investment tips and comprehensive analysis through the Pro Research Report, offering deeper insights into LifeVantage's growth trajectory and market ...